Patents by Inventor Douglas A. Triplett

Douglas A. Triplett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5922587
    Abstract: It was found that the use of a phospholipid dependent prothrombin activator purified from the venom of snakes belonging to the Elapidae family, especially members of the Oxyuranus and Psuedonaja genera is most useful in tests for the determination of Lupus Anticoagulant. Based on this, several clotting, chromogenic and immunochromogenic tests have been developed.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 13, 1999
    Assignee: Pentapharm AG
    Inventors: Douglas A. Triplett, Kurt Stocker
  • Patent number: 5705198
    Abstract: It was found that the use of a phospholipid dependent prothrombin activator purified from the venom of snakes belonging to the Elapidae family, especially members of the Oxyaranus and Psuedonaja genera is most useful in tests for the determination of Lupus Anticoagulant. Based on this, several clotting, chromogenic aria immunochromogenic tests have been developped.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 6, 1998
    Assignee: Pentapharm AG
    Inventors: Douglas A. Triplett, Kurt Stocker
  • Patent number: 5453370
    Abstract: A method for the preparation of a phospholipid-dependent prothrombin activator from the venom of snakes belonging to the Elapidae family, the activator comprising an increased plasma clotting activity in the presence of phospholipids and calcium ions; a reduced activity in the presence of Lupus Anticoagulant; an ability to facilitate clotting in a normal clotting time in the presence of platelet poor plasma, the plasma having normal or decreased levels of factor V, VII, VIII, IX, or X; and a major band with a molecular weight of 40,000 to 60,000 daltons on an SDS gel.
    Type: Grant
    Filed: November 30, 1992
    Date of Patent: September 26, 1995
    Assignee: Pentapharm AG
    Inventors: Douglas A. Triplett, Kurt Stocker